Ovid Therapeutics Inc. (OVID) has 1 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: July 8, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| July 8, 2026 filed July 6, 2026 | Carter Charles Ross Chief Financial Officer | $0 | 50,000 | +113% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free